Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA?

Authors’ reply

  • Ranganathan, P
  • McLeod, H L

  • Washington University School of Medicine, Division of Rheumatology, Box 8045, St Louis 63110, USA

Correspondence to: Dr P Ranganathan; [email protected]

Annals of the Rheumatic Diseases 62(6):p 591-592, June 2003.
Copyright © 2003 by the Annals of the Rheumatic Diseases